Donald Harvey, MD
Plastic Surgery · Cleveland, OHNPI 1831415843
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (56.4%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. 17 manufacturers reported payments, led by AbbVie at 54.2% of the total.
Across 69 payments — averaging $128.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$5K
- Musculoskeletal Transplant Foundation Inc.$1K
- Integra Lifesciences Corporation$396
- RTI Surgical, Inc$368
- Sientra, Inc.$332
- Johnson & Johnson$209
- plus $1K from 11 others
What the payments were for
- Consulting fees$1,54017%
- Travel & lodging$2,23025%
- Food & beverage$5,01056%
- Entertainment$1001%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 29 | $4,816 |
| Musculoskeletal Transplant Foundation Inc. | 8 | $1,463 |
| Integra Lifesciences Corporation | 9 | $396 |
| RTI Surgical, Inc | 2 | $368 |
| Sientra, Inc. | 2 | $332 |
| Johnson & Johnson | 2 | $209 |
| Derma Sciences, Inc. | 1 | $172 |
| Mentor Worldwide LLC | 3 | $166 |
| Davol Inc. | 1 | $150 |
| Smith+Nephew | 2 | $149 |
| Baxter Healthcare | 1 | $145 |
| Axogen | 2 | $143 |
| TELA Bio, Inc. | 2 | $122 |
| KCI USA, Inc. | 1 | $94 |
| Stryker | 2 | $70 |
| Vioptix Inc | 1 | $59 |
| Kerecis Limited | 1 | $28 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NATRELLE SALINE-FILLED BREAST IMPLANTS$5,392
- STRATTICE RECONSTRUCTIVE TISSUE MATRIX BPS$1,722
- REVOLVE$1,722
- NATRELLE$432
- FORTIVA PORCINE DERMIS$368
- SIENTRA HIGH STRENGTH COHESIVE SILICONE GEL BREAST IMPLANT$332
- PRIMATRIX$320
- AMNIOEXCEL$172
- TCC-EZ$172
- IDRT$172
- OMNIGRAFT$172
- PHASIX$150
- INTEGRA MESHED BILAYER WOUND MATRIX$148
- INTEGRA WOUND MATRIX (IWM)$148
- INTEGRA DERMAL REGENERATION TEMPLATE$148
- INTEGRA FLOWABLE WOUND MATRIX$148
- ARTISS$145
- PICO 7 Single Use Negative Pressure Wound Therapy$140
- DISTRACTION OSTEOGENESIS SYSTEMS$123
- ARTIA$121
How this compares
$8,881 in reported general payments places this provider in the 80th percentile of 191 plastic surgery providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone Hcl | 19 | $54 |
Paid to pharmacies, not to this prescriber.
Other plastic surgery in Cleveland
- Christopher SurekCleveland$1M
- Risal DjohanCleveland$330K
- Brian GastmanCleveland$88K
- Anthony TufaroCleveland$56K
- Maria SiemionowCleveland$28K
- Sarah BishopCleveland$24K
- Rachel AliottaCleveland$14K
- Meenakshi RajanCleveland$14K
- Jacob GrowCleveland$8K
- Raymond IsakovCleveland$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.